Regulation of Dopamine D1 Receptor Function by Physical Interaction with the NMDA Receptors

Journal of Neuroscience

Volumn 24, Issue 5, 2004, Pages 1149-1158

  Pei, Lin ^a   Lee, Frank J S ^a,d   Moszczynska, Anna ^a   Vukusic, Brian ^a   Liu, Fang ^a,b,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

cAMP accumulation; Dopamine receptors; G proteins; NMDA receptors; Protein protein interactions; Receptor trafficking

Indexed keywords

CYCLIC AMP; DOPAMINE 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SNARE PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIDNEY CELL; NERVE CELL CULTURE; NEUROBIOLOGY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SCHIZOPHRENIA;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; EXOCYTOSIS; HIPPOCAMPUS; HUMANS; MEMBRANE FUSION; N-METHYLASPARTATE; NEURONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE; TRANSFECTION;

EID: 0842304133     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3922-03.2004     Document Type: Article

References (59)

1. Barria A, Malinow R (2002) Subunit-specific NMDA receptor trafficking to synapses. Neuron 35:345-353.
2. Brimecombe JC, Boeckman FA, Aizenman E (1997) Functional consequences of NR2 subunit composition in single recombinant N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 94:11019-11024.
3. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260.
4. Castner SA, Williams GV, Goldman-Rakic PS (2000) Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 287:2020-2022.
5. Cepeda C, Radisavljevic Z, Peacock W, Levine MS, Buchwald NA (1992) Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex. Synapse 11:330-341.
6. Chu P, Murray S, Lissin D, von Zastrow M (1997) Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272:27124-27130.
7. Claing A, Laporte SA, Caron MG, Lefkowitz RJ (2002) Endocytosis of G-protein-coupled receptors: roles of G-protein-coupled receptor kinases and β-arrestin proteins. Prog Neurobiol 66:61-79.
8. Colwell CS, Levine MS (1995) Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms. J Neurosci 15(Pt 1):1704-1713.
9. Davidson M, Harvey PD, Bergman RL, Powchik P, Kaminsky R, Losonczy MF, Davis KL (1990) Effects of D1 agonist SKF-38393 combined with haloperidol in schizophrenic patients Arch Gen Psychiatry 47:190-191.
10. Dean B, Scarr E, Bradbury R, Copolov D (1999) Decreased hippocampal NMDA receptors in schizophrenia. Synapse 32:67-69.
11. Demchyshyn LL, McConkey F, Niznik HB (2000) Dopamine D5 receptor agonist high affinity and constitutive activity profile conferred by carboxyl-terminal tail sequence. J Biol Chem 275:23446-23455.
12. Durand GM, Gregor P, Zheng X, Bennett MV, Uhl GR, Zukin RS (1992) Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci USA 89:9359-9363.
13. Ehlers MD, Zhang S, Bernhadt JP, Huganir RL (1996) Inactivation of NMDA receptors by direct interaction of calmodulin with the NR1 subunit. Cell 84:745-755.
14. Ehlers MD, Fung ET, O'Brien RJ, Huganir RL (1998) Splice variant-specific interaction of the NMDA receptor subunit NR1 with neuronal intermediate filaments. J Neurosci 18:720-730.
15. Fiorentini C, Gardoni F, Spano P, Luca MD, Missale C (2003) Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem 278:20196-20202.
16. Gao XM, Sakai K, Roberts R, Conley RR, Dean B, Tamminga CA (2000) Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 157:1141-1149.
17. Garcia-Gallo M, Behrens MM, Renart J, Diaz-Guerra M (1999) Expression of N-methyl-D-aspartate receptors using vaccinia virus causes excitotoxic death in human kidney cells. J Cell Biochem 72:135-144.
18. Goff DC, Coyle JT (2001) The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158:1367-1377.
19. Goldman-Rakic PS (1999) The relevance of the dopamine-D1 receptor in the cognitive symptoms of schizophrenia. Neuropsychopharmacology 21:S170-S180.
20. Greengard P (2001) The neurobiology of slow synaptic transmission. Science 297:1024-1030.
21. 2+-exposed rats: implications for synaptic targeting and cell surface expression of NMDAR complexes. Brain Res Mol Brain Res 113:37-43.
22. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108.
23. Hollmann M, Boulter J, Maron C, Beasley L, Sullivan J, Pecht G, Heinemann S (1993) Zinc potentiates agonist-induced currents at certain splice variants of the NMDA receptor. Neuron 10:943-954.
24. Hua SY, Charlton MP (1999) Activity-dependent changes in partial VAMP complexes during neurotransmitter release. Nat Neurosci 2:1078-1083.
25. Huang KX, Bergstrom DA, Ruskin DN, Walters JR (1998) N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Synapse 30:18-29.
26. Huang YY, Kandel ER (1995) D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci USA 92:2446-2450.
27. Iversen SD (1995) Interactions between excitatory amino acids and dopamine systems in the forebrain: implications for schizophrenia and Parkinson's disease. Behav Pharmacol 6:478-491.
28. Javitt DC (2001) Management of negative symptoms of schizophrenia. Curr Psychiatry Rep 3:413-417.
29. Jentsch JD, Redmond DE, Elsworth JD, Taylor JR, Youngren KD, Roth RH (1997) Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277:953-955.
30. Karoor V, Wang L, Wang HY, Malbon CC (1998) Insulin stimulates sequestration of β-adrenergic receptors and enhanced association of β-adrenergic receptors with Grb2 via tyrosine 350. J Biol Chem 273:33035-33041.
31. Keefe KA, Ganguly A (1998) Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: evidence for involvement of pharmacologically distinct NMDA receptors? Dev Neurosci 20:216-228.
32. Konradi C, Leveque JC, Hyman SE (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 16:4231-4239.
33. Krupp JJ, Vissel B, Heinemann SF, Westbrook GL (1996) Calcium-dependent inactivation of recombinant N-methyl-D-aspartate receptors is NR2 subunit specific. Mol Pharmacol 50:1680-1688.
34. Lee FJS, Xue S, Pei L, Vukusic B, Nadege C, Wang YS, Wang YT, Niznik HB, Yu XM, Liu F (2002) Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111:219-230.
35. Lidow MS, Williams GV, Goldman-Rakic PS (1998) The cerebral cortex: a case for a common site of action of anti-psychotics. Trend Pharmacol Sci 19:136-140.
36. Lin JW, Wyszynski M, Madhavan R, Sealock R, Kim JU, Sheng M (1998) Yotiao, a novel protein of neuromuscular junction and brain that interacts with specific splice variants of NMDA receptor subunit NR1. J Neurosci 18:2017-2027.
37. Liu F, Yuan Y, Sugamori KS, Hamadanizadeh A, Lee FJS, Pang SF, Brown GM, Pristupa ZB, Niznik HB (1995) Molecular and functional characterization of a partial cDNA encoding a novel chicken brain melatonin receptor. FEBS Lett 374:273-278.
38. Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB (2000) Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature 403:274-280.
39. Lu W, Man H, Ju W, Trimble WS, MacDonald JF, Wang YT (2001) Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons. Neuron 29:243-254.
40. Maletic-Savatic M, Malinow R (1998) Calcium-evoked dendritic exocytosis in cultured hippocampal neurons. Part I: trans-Golgi network-derived organelles undergo regulated exocytosis. J Neurosci 18:6803-6813.
41. Man HY, Lin JW, Ju WH, Ahmadian G, Liu L, Becker LE, Sheng M, Wang YT (2000) Regulation of AMPA receptor-mediated synaptic transmission by clathrin-dependent receptor internalization. Neuron 25:649-662.
42. Michaelis EK (1998) Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress, and aging. Prog Neurobiol 54:369-415.
43. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78:189-225.
44. Mohn AR, Gainetdinov RR, Caron MG, Koller B (1999) Mice with reduced NMDA receptor expression display behaviors-related schizophrenia. Cell 98:427-436.
45. Olney JW, Farber NB (1995) Glutamate receptor dysfunction in schizophrenia. Arch Gen Psychiatry 52:998-1007.
46. Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251:947-950.
47. Schreiber AB, Schlessinger J, Edidin M (1984) Interaction between major histocompatibility complex antigens and epidermal growth factor receptors on human cells. J Cell Biol 98:725-731.
48. Scott L, Kruse MS, Forssberg H, Brismar H, Greengard P, Aperia A (2002) Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation. Proc Natl Acad Sci USA 99:1661-1664.
49. Sprengel R, Suchanek B, Amico C, Brusa R, Burnashev N, Rozov A, Hvalby O, Jensen V, Paulsen O, Andersen P, Kim JJ, Thompson RF, Sun W, Webster LC, Grant SG, Eilers J, Konnerth A, Li J, McNamara JO, Seeburg PH (1998) Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell 92:279-289.
50. Standley S, Roche KW, McCallum J, Sans N, Wenthold RJ (2000) PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 28:887-898.
51. Sugihara H, Moriyoshi K, Ishii T, Masu M, Nakanishi S (1992) Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing. Biochem Biophys Res Commun 185:826-832.
52. Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y (1990) Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347:80-83.
53. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Tol HH, Niznik HB (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350:614-619.
54. Tamminga CA (1998) Schizophrenia and glutaminergic transmission. Crit Rev Neurobiol 12:21-36.
55. Thornberg SA, Saklad SR (1996) A review of NMDA receptors and the phencyclidine model of schizophrenia. Pharmacotherapy 16:82-93.
56. Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, Wolfe BB, Grayson DR (1998) Functional and pharmacological differences between recombinant N-methyl-D-aspartate receptors. J Neurophysiol 79:555-566.
57. Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572-575.
58. Wyszynski M, Lin J, Rao A, Nigh E, Beggs AH, Craig AM, Sheng M (1997) Competitive binding of α-actinin and calmodulin to the NMDA receptor. Nature 385:439-442.
59. Ziff EB (1997) Enlightening the postsynaptic density. Neuron 19:1163-1174.